Literature DB >> 3203697

Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics.

P Rinieris1, J Hatzimanolis, M Markianos, C Stefanis.   

Abstract

Serum prolactin (PRL), luteinizing hormone (LH) and testosterone (T) levels were estimated in a group of 30 male paranoid schizophrenics before and after 4 weeks treatment with chlorpromazine and/or trihexyphenidyl, and in a group of 14 healthy male individuals. After treatment with chlorpromazine (100 mg t.i.d., p.o.), 10 patients presented a significant increase in serum PRL values and a significant decrease in serum T values. A significant increase in serum PRL values was also found in 10 patients who were treated with chlorpromazine (100 mg t.i.d., p.o.) plus trihexyphenidyl (5 mg t.i.d., p.o.). No significant difference in any of the investigated endocrine parameters was detected in 10 patients after 4 weeks administration of trihexyphenidyl (5 mg t.i.d., p.o.). Following chlorpromazine treatment with or without concomitant administration of trihexyphenidyl, 20 patients showed a significant increase in serum PRL levels and a significant decrease in serum LH and T levels.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3203697     DOI: 10.1007/bf00449905

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  26 in total

1.  Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patients.

Authors:  R Martin-du Pan; P Baumann; G Magrini; J P Felber
Journal:  Psychoneuroendocrinology       Date:  1978-10       Impact factor: 4.905

Review 2.  Central neurotransmitters and the secretion of prolactin, GH, LH and TSH.

Authors:  L Krulich
Journal:  Annu Rev Physiol       Date:  1979       Impact factor: 19.318

3.  Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.

Authors:  T Kolakowska; D H Wiles; M G Gelder; A S McNeilly
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

4.  Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.

Authors:  T E Hanlon; C Schoenrich; W Freinek; I Turek; A A Kurland
Journal:  Psychopharmacologia       Date:  1966

5.  Plasma prolactin and testosterone during penfluridol treatment.

Authors:  R S Nathan; G M Asnis; I Dyrenfurth; F S Halpern; U Halbreich; L C Ostrow; E J Sachar
Journal:  Lancet       Date:  1980-07-12       Impact factor: 79.321

6.  A standardized psychiatric assessment scale for rating chronic psychotic patients.

Authors:  M Krawiecka; D Goldberg; M Vaughan
Journal:  Acta Psychiatr Scand       Date:  1977-04       Impact factor: 6.392

7.  Effect of the anticholinergic drug biperiden on pituitary hormones and cortisol.

Authors:  O Benkert; H E Klein; E Hofschuster; C Seibold
Journal:  Psychoneuroendocrinology       Date:  1981       Impact factor: 4.905

8.  Biochemical research into psychosis.

Authors:  H M van Praag; J Korf
Journal:  Acta Psychiatr Scand       Date:  1975-05       Impact factor: 6.392

9.  Neuroendocrine effects of haloperidol therapy in chronic schizophrenia.

Authors:  F Brambilla; A Guerrini; A Guastalla; C Rovere; F Riggi
Journal:  Psychopharmacologia       Date:  1975-10-14

10.  Effect of benztropine on haloperidol-induced prolactin secretion.

Authors:  S Lal; T Mendis; P Cervantes; H Guyda; J L DeRivera
Journal:  Neuropsychobiology       Date:  1979       Impact factor: 2.328

View more
  2 in total

Review 1.  Sex steroids and schizophrenia.

Authors:  Julie A Markham
Journal:  Rev Endocr Metab Disord       Date:  2012-09       Impact factor: 6.514

2.  Concentrations of homovanillic Acid and gonadal hormones in the serum of male schizophrenic patients.

Authors:  S L Gong; J Wei; C N Ramchand; R Ramchand; G P Hemmings
Journal:  Indian J Psychiatry       Date:  1993-07       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.